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“If you're going to try, go all the way. Otherwise, don't even start. This could mean losing 
girlfriends, wives, relatives and maybe even your mind. It could mean not eating for three or 
four days. It could mean freezing on a park bench. It could mean jail. It could mean derision. It 
could mean mockery - isolation. Isolation is the gift. All the others are a test of your endurance, 
of how much you really want to do it. And, you'll do it, despite rejection and the worst odds. 
And it will be better than anything else you can imagine. If you're going to try, go all the way. 
There is no other feeling like that. You will be alone with the gods, and the nights will flame 
with fire. You will ride life straight to perfect laughter. It's the only good fight there is.”  
― Charles Bukowski, Factotum 
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Resumo 
 
A meningite neonatal induzida por bactérias é uma importante causa de 
mortalidade e morbilidade em todo o mundo. Streptococcus agalactiae, mais 
comummente designado por Estreptococos do Grupo B (do Inglês GBS) é o 
responsável pela maioria dos casos de meningite neonatal. A colonização materna dos 
tratos gastrointestinal e genitourinário são a principal fonte de infeção dos recém-
nascidos. Apesar das melhorias nos cuidados neonatais e da implementação de 
medidas antimicrobianas, a taxa de mortalidade associada a este microrganismo é de 
10%. Além disso, até cerca de 50% dos sobreviventes da meningite causada por GBS 
desenvolvem graves sequelas neurológicas. Ainda existe uma grande lacuna no 
conhecimento da patogénese desta doença, apesar da existência de vários modelos 
de experimentação animal de meningite neonatal. Uma possível explicação é que 
nenhum destes modelos utiliza a via de infeção que ocorre nos humanos. No nosso 
laboratório estamos a desenvolver um modelo que mimetiza a via de infeção humana. 
Neste sentido, fêmeas BALB/c grávidas foram infetadas intra-vaginalmente com 105 
células de GBS BM110, estirpe responsável pela maioria dos casos de meningite 
humana. Após o parto, a colonização do trato vaginal das fêmeas e a carga bacteriana 
presente nos descendentes foram monitorizadas em diferentes tempos. Os resultados 
obtidos mostraram que as fêmeas estavam altamente colonizadas até ao quarto dia 
após o parto e que, a bactéria foi transmitida às ninhadas. De fato, GBS foi encontrado 
nos pulmões, no sangue, no fígado e no cérebro dos ratinhos recém-nascidos, a 
diferentes tempos após o parto. Análise histopatológica dos cérebros de ratinhos 
infetados mostrou que estes apresentavam as caraterísticas típicas de meningite: 
espessamento das meninges, hemorragias cerebrais e influxo de células inflamatórias. 
Aproximadamente 40% da descendência morreu após o parto, um valor semelhante 
ao descrito em humanos antes da implementação da profilaxia antibiótica intrapartum. 
De modo a confirmar se os animais sobreviventes à semelhança do descrito em 
humanos apresentavam sequelas neurológicas, foram avaliados, na idade adulta, o 
seu desempenho cognitivo e motor bem como os padrões de neurotransmissores em 
diferentes secções de cérebro. A avaliação cognitiva foi determinada usando o Radial 
Maze Test, e a atividade locomotora e comportamento exploratório foram avaliados 
usando o Open Field Test. Após os testes, os animais foram sacrificados e diferentes 
secções dos seus cérebros foram utilizadas para medir as concentrações de 
neurotransmissores. Ratinhos sobreviventes à infeção por GBS apresentaram um 
maior número de erros cometidos quando comparados com os controlos. Estes erros 
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estão associados com os níveis de glutamato no hipocampo que se encontravam 
diminuídos no grupo de ratinhos que sobreviveram à infeção. Os resultados obtidos no 
Open Field Test indicaram que estes ratinhos são menos ativos, uma vez que 
apresentaram atividade locomotora e comportamento exploratório diminuídos quando 
comparados com o grupo controlo. Estes resultados estavam associados com os 
níveis diminuídos de glutamato no tálamo e com os níveis diminuídos de dopamina e 
seus metabolitos no hipocampo e no estriado dos ratinhos sobreviventes, quando 
comparados com os controlos. Foram assim observadas alterações neurológicas nos 
ratinhos que sobreviveram à infeção neonatal por GBS. 
Em conjunto, estes resultados indicam que o nosso modelo mimetiza o que 
acontece nos humanos, sendo por isso um bom modelo para ser usado na 
caracterização da patogénese e patofisiologia da meningite induzida por GBS. 
 
Palavras-Chave: Meningite neonatal; Streptococcus do Grupo B; modelo 
experimental; neurotransmissores; comportamento 
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Abstract 
 
Bacterial meningitis is a substantial cause of morbidity and mortality in 
neonates. Group B Streptococcus (GBS), a common designation for Streptococcus 
agalactiae, is the main agent of neonatal meningitis. Maternal colonization with GBS in 
the genitourinary and/or gastrointestinal tracts is the source of the neonatal infection. 
Despite early antimicrobial treatment and improvement in neonatal intensive care, up to 
10% of neonatal invasive GBS infections are lethal and up to 50% of surviving infants 
with meningitis present neurological sequelae. Significant gaps in knowledge of the 
pathogenesis of this disease still remain despite several animal models have been 
used. All these models use artificial routes of infection. Our research team is 
developing a murine model of neonatal GBS-induced diseases, which addresses the 
natural course in human pathogenesis of ascending infection from the lower genital 
tract to neonates. Here, we characterize the suitability of this animal model to study the 
neonatal meningitis induced by GBS. For that purpose, pregnant BALB/c female mice 
were infected intra-vaginally with 105cells of GBS BM110, a strain responsible for the 
majority of human cases of meningitis. Pregnant female were allowed to deliver and 
their vaginal tract colonization and the bacterial transfer into the newborns, were 
monitored at different time points after birth. The obtained results showed that mothers 
remained highly colonized until the fourth day after delivery and the bacterium was 
transmitted to their progeny. Indeed, GBS was found in the lungs, blood, liver and 
brain, of pups at different time points after birth. Histopathological analysis of the brains 
of infected pups showed the classical features of meningitis such as: meningeal 
thickening, cerebral bleeding and massive influx of inflammatory cells. Approximately 
40% of the progeny died, a value close to that reported for the initial case-fatality 
observed in humans, before the introduction of intrapartum antibiotic therapy. To 
confirm that the surviving animals present neurological sequelae, we determined their 
cognitive and motor performance in adult life, and identified whether an altered 
neurotransmission pattern was involved. The cognitive evaluation was performed in a 
complex learning task using the Radial Maze test and the anxiety levels, locomotor 
activity and exploratory behavior were measured through Open Field Test. After the 
tests, the animals were sacrificed and the different brain regions were used for 
determination of neurotransmitter levels. Mice that survived to neonatal GBS infection 
presented increased working and reference memories errors when compared with the 
non-infected controls, which were associated with the decrease in the glutamate levels 
in the hippocampus. Results from Open Field Test, showed that mice survivors to GBS 
infection, were less active since they present decreased locomotor activity and 
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exploratory behavior than the non-infected controls. These results are associated with 
the lower levels of glutamate in the thalamus and also with the diminished levels of 
dopamine and its metabolites in the hippocampus and in the striatum of GBS-survivors 
comparatively with non-infected controls. 
Altogether these results indicate that our mouse model closely mimics the 
characteristics observed in humans and, therefore, could be used to characterize the 
pathogenesis and pathophysiology of meningitis induced by GBS.  
  
Keywords: Neonatal meningitis; Group B Streptococcus; experimental model; 
neurotransmitters; behavior 
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1. Neonatal Bacterial Meningitis 
 
1.1 Overview 
Neonatal bacterial meningitis is a serious life-threatening disease and a major 
cause of disability worldwide, despite advances in health care, in the development of 
more effective antibiotics, and in greater tools for rapid pathogen identification 
(Gaschignard et al., 2011). 
At birth, all organ systems of the neonate switch from a highly controlled intra-
uterine environment to the drastically different surroundings of the outside world.  
This uttermost transition is then followed by a gradual, age-dependent 
maturation. Actually, prenatal immune system maturation cannot be fully conducted 
until neonates lose their status of privileged allograft, surrounded by a great number of 
maternal antigens, the fetus remains in his ‘sterile world’, unresponsive to any 
challenge. Yet, the immune system is prepared to cope with the dramatic changes that 
occur during birth, as newborns respond to microbes from the circling new non-sterile 
environment. 
Nevertheless, neonates are at greater risk of developing infections, sepsis and 
meningitis when compared to other age groups as their immune system is not fully 
mature. Deficiencies in humoral and cellular immunity are setbacks that make them 
more susceptible to infections. The defects in adaptive immunity are well described 
[reviewed in (Adkins et al., 2004)],  as they do not have immunological memory, are 
unable to produce high levels of IgG against encapsulated bacteria, produce less 
efficient inflammatory cytokines and also they are committed to produce the 
immunosuppressive/immunoregulatory cytokine IL-10 (Madureira et al., 2007, 
Madureira et al., 2011). Thus, neonates must rely on their innate immune system for 
protection against pathogens (Krishnan et al., 2003, Firth et al., 2005). Nevertheless, 
newborns have a diminished bone marrow pool, and therefore their ability to accelerate 
neutrophil production in response to infection is limited (Koenig and Yoder, 2004). Also, 
neutrophil recruitment in neonates is reduced (Koenig and Yoder, 2004). Moreover, the 
phagocyte function is diminished in neonates, especially in premature babies. 
(Falconer et al., 1995). 
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1.2 Epidemiology 
The  incidence value for neonatal bacterial meningitis may be underestimated 
as it is very hard to determine accurately due to a range wide of factors, which include: 
the difficulty in diagnosing neonatal meningitis, variations between hospital-based and 
community studies, regional differences and unregistered deaths in areas where the 
access to proper health care is poor or almost inexistent (Osrin et al., 2004). Moreover, 
although most data evidence derives from developed countries, the major burden of 
neonatal sepsis and meningitis occurs in the developing world (Furyk et al., 2011), 
where health care and data acquisition are unevaluated. Thus, it is obvious that the 
existing data does not reflect the true incidence of bacterial meningitis. 
In industrialized developed countries, bacterial meningitis incidence is 
approximately 0.3 per 1,000 live births (Brouwer et al., 2010). The World Health 
Organization (WHO) estimates that there are 5 million neonatal deaths per year and 
that approximately 98%, an overwhelming majority, occurs in developing countries 
(Furyk et al., 2011). Neonatal meningitis contributes significantly to this shocking 
statistics, as it is recognized as one of the top ten causes of infection-related death 
worldwide (Fauci, 2001), with 126,000 cases annually and more than 50,000 deaths 
(Stoll, 1997, Weber et al., 2003). 
Mortality from neonatal meningitis in developing countries is estimated to be 40-
58%, against 10% in developed countries (Furyk et al., 2011). A study conducted 
throughout Asia reported an estimated incidence of neonatal meningitis from 0.48 per 
1000 live births in Hong Kong, whereas in Kuwait, an incidence rate of 2.4 per 1,000 
births (Tiskumara et al., 2009). In another study focused in neonatal infections in Africa 
and in South Asia, an incidence of neonatal meningitis ranging from 0.8 to 6.1 per 
1,000 live births was reported (Thaver and Zaidi, 2009).  
Group B Streptococcus is, beyond the neonatal period, the most common 
cause of bacterial meningitis, accounting for approximately 80% of cases among those 
less than 2 month of age (Schrag, 2011). Escherichia coli is the second pathogen 
(Klinger et al., 2000) and Listeria monocytogenes, the third, and it possesses the 
unique characteristic of transplancental transmission (Heath et al., 2003). In Portugal, 
GBS is the most common isolate in early onset neonatal sepsis. A survey from 2008 in 
Portuguese infants younger than 90 days, estimated an overall incidence of invasive 
GBS disease of 0.54 per 1,000 live births, with a mortality rate of 6.6% (Neto, 2008). 
Moreover, this incidence also varies from one geographic area to another, as 
approximately 35% of pregnant women from the north are colonized with GBS, 
contrasting with the 13% found in the south (Neto, 2008). 
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Table 1 summarizes the most common pathogens responsible for central 
nervous system (CNS) infections and meningitis. 
 
Table 1 – Pathogens commonly causing central nervous system infections in humans 
 
Pathogen Reference 
Streptococcus agalactiae (Group B Streptococcus) (Brochet et al., 2008, Heath et al., 2009, Edmond et al., 2012) 
Escherichia coli (Klinger et al., 2000, Gaschignard et al., 2012) 
Listeria monocytogenes (Heath et al., 2003, Fayol et al., 2009) 
Streptococcus pneumoniae (O'Brien et al., 2009) 
Neisseria meningitidis (Kurlenda et al., 2010) 
Haemophilus influenzaetype b (Watt et al., 2009) 
Mycobacterium tuberculosis (Farinha et al., 2000) 
Borrelia burgorferi (Avery et al., 2005) 
Candida albicans (Aleixo et al., 2000) 
Trypanossoma spp. (Finsterer and Auer, 2013) 
 
 
Although the mortality rate in developed countries declined almost from 50% in 
the 1970’s to approximately 10% in the late 90’s (Berardi et al., 2010), the morbidity 
rates are still high, as meningitis remains a major source of disability and long term 
sequelae (Puopolo et al., 2005). Neonatal meningitis survivors are at risk for 
developing moderate to severe disability, which include: problems in language, motor 
function, hearing, vision and cognition and also 5 to 20% have future epilepsy. Besides, 
survivors may also present more subtle symptoms: visual deficits, middle-ear disease 
and behavioral problems (Bedford et al., 2001). In a 2001 study, regarding a sample 
superior to 1500 neonates from the England and Wales with surviving until the age of 
5, several neuro-motor disabilities were reported as cerebral palsy (8.1%), learning 
disability (7.5%), seizures (7.3%) and hearing problems (25.8%) (Bedford et al., 2001). 
 
1.3 Streptococcus agalactiae 
Streptococcus agalactiae is a Gram positive encapsulated bacterium which 
appears as diplococci or as a chain (Doran and Nizet, 2004, Nandyal, 2008). It is a 
catalase negative, beta-hemolytic microorganism and it is a facultative anaerobic, 
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growing preferentially in oxygen absence. During the 30’s, Rebecca Lancefield 
observed that hemolytic Streptococcus from human and animal origins could be 
divided and distinguished serologically according to their polysaccharide capsule 
composition (Lancefield, 1933, 1934a). Moreover, five Streptococcus groups were then 
discovered: A, B, C, D and E (Lancefield, 1934b). In line with this type of classification, 
the most common designation for S. agalactiae, Group B Streptococcus (GBS), was 
implemented. Lancefield was also able to sub-divide GBS into different serotypes using 
the antigen immunogenicity of the polysaccharide capsule as criteria (Lancefield, 
1934b). Currently there are ten known GBS serotypes:  Ia, Ib, II, III, IV, V, VI, VII, VIII 
(Doran and Nizet, 2004, Shet and Ferrieri, 2004, Slotved et al., 2007). 
Still during the 30’s, Lancefield and Hare isolated GBS for the first time from the 
vaginal tract of a woman after having birth [reviewed by (Mulder and Zanen, 1984)] and 
three years later, Fry observed cultured GBS collected from women during delivery. 
Despite these facts, little knowledge of GBS role in neonatal infections was obtained 
during the next thirty years. It was only in 1964 that Eichkoff highlighted the importance 
of this pathogen in the previously stated subject. In the late 70’s, GBS outstripped       
E. coli as the most important cause of newborn septicemia in the United States of 
America. Nowadays, GBS continues to be one of the major pathogens responsible for 
neonatal bacterial meningitis and septicemia (Stoll et al., 2011). 
The Lancefield division does not demonstrate the true biodiversity regarding the 
existing GBS strains, as strains that belonging to different serotypes can be more 
related at a genetic level  than strains from the same serotype (Davies et al., 2004, 
Tettelin et al., 2005). 
A more profound knowledge about serotype relations was needed and 
multilocus sequence typing (MLST) was applied. This is a very important molecular 
biology technique and it is used to type multiple loci. This procedure characterizes 
microbial isolates using the DNA sequences of internal fragments of housekeeping 
genes (Davies et al., 2004). Approximately 450-500 bp internal fragments of each gene 
are used, as these can be accurately sequenced on both strands using an automated 
DNA sequencer. For each housekeeping gene, the different sequences present within 
a bacterial species are assigned as distinct alleles and, for each isolate, the alleles at 
each of the loci define the allelic profile or sequence type (ST). After the 
characterization of the GBS MLST profile, it was observed that isolates with the same 
sequence can actually belong to different capsular serotypes. From all known 
serotypes, serotype III seems to be the most virulent and it is very closely associated 
with most of the cases of neonatal meningitis (Nandyal, 2008). 
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2. GBS Disease 
 
2.1 Risk Factors 
GBS maternal colonization is the primary risk factor for the development of 
bacterial infections (Verani et al., 2010). The gastrointestinal tract is a natural reservoir 
for GBS and is likely the source of vaginal colonization (Dillon et al., 1982, Hoogkamp-
Korstanje et al., 1982). In addition, a study suggested that the vagina becomes 
colonized with GBS as a result of its transfer from the rectum into the vagina, stating 
that rectal GBS colonization is a major predictor and risk factor for vaginal colonization 
(Meyn et al., 2009). Up to 30% of both sex individuals are commonly colonized with this 
bacteria in the gastrointestinal and genital tracts but remain asymptomatic. Importantly, 
30% of the asymptomatic individuals are pregnant women colonized in the vaginal tract 
(Verani et al., 2010). Moreover, the carriage rate in the vaginal and rectal microbiota 
ultimately ranges between 10 to 37% and it’s the same in both developing and 
developed countries (Bergeron et al., 2000, Verani and Schrag, 2010). 
GBS colonization during pregnancy can be transient, intermittent, or persistent 
(Lewin and Amstey, 1981, Hoogkamp-Korstanje et al., 1982, Hansen et al., 2004). 
Some women with GBS colonization during a pregnancy will be colonized during 
subsequent pregnancies (Cheng et al., 2008, Turrentine and Ramirez, 2008). 
Nevertheless, previous delivery of an infant with invasive GBS disease is a risk factor 
for early-onset disease in subsequent deliveries (Carstensen et al., 1988, Faxelius et 
al., 1988, Schrag et al., 2002b). In addition to maternal colonization with GBS, other 
parameters increase the risk for neonatal infections such as: gestational age inferior to 
37 completed weeks, abnormally longer duration of membrane rupture, intra-amniotic 
infection, young maternal age, black race, and low maternal levels of GBS-specific anti-
capsular antibody (Baker et al., 1981, Boyer et al., 1983, Schuchat et al., 1994, 
Schuchat et al., 2000, Zaleznik et al., 2000, Oddie and Embleton, 2002, Adair et al., 
2003). 
 
2.2 Early-Onset and Late-Onset Disease 
Epidemiologically, neonatal GBS disease is divided in two distinct forms, early-
onset disease (EOD), occurring between 0-6 days after birth, and late onset disease 
(Barichello et al.), starting after the first week of life until day 89 (Phares et al., 2008).  
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Infants with GBS EOD generally present respiratory distress, apnea, or other 
signs of sepsis within the first 24–48 hours of life (Franciosi et al., 1973, Baker, 1978). 
The most common clinical syndromes of early-onset disease are sepsis and 
pneumonia but even though less frequently, early-onset infections can lead to 
meningitis. The case-fatality ratio of EOD has declined from as high as 50% in the 
1970s (Baker and Barrett, 1974). In contrast, the progression of the infection to a state 
of meningitis, which is the most common manifestation of LOD, did not decline 
(Nandyal, 2008). Early-onset infections develop mainly in utero because GBS is able to 
ascend to the amniotic cavity, contaminating the amniotic fluid (Desa and Trevenen, 
1984). Also, neonatal infection can be acquired during labor through exposure to GBS 
present in the vagina of a colonized woman (Katz and Bowes, 1988). 
In relation to GBS LOD cases, the route of infection is not well known. It can be 
acquired from birth, as approximately 50% of the infants with LOD are colonized at 
delivery time with the same GBS serotype as the mother (Dillon et al., 1987), or it can 
be acquired from environmental sources (Berardi et al., 2013b). Horizontal 
transmission during the perinatal period may occur from mother to infant or from 
hospital or community sources (Melin, 2011). Another reported source of infection is 
breastfeeding (Godambe et al., 2005, Gagneur et al., 2009), although this has been 
under discussion in the scientific community as opinions differ (Berardi et al., 2013b). 
Nevertheless, it is thought that the bacterium is acquired by swallowing of infected 
maternal vaginal secretions during birth, leading to a persistent infection that 
culminates in its dissemination and in the later development of meningitis (Nandyal, 
2008). 
As illustrated in Figure 1, the first focus of infection is the lungs, as both vaginal 
fluid and amniotic fluid can be inspired. GBS caused pneumonia is characterized by 
severe pulmonary lesions, with bacterial infiltrates, hemorrhage and protein exudates 
into the alveolar space (Doran and Nizet, 2004). Thereby, lungs are an important 
gateway for bacterial infections, giving access to the bloodstream. The main 
consequences are bacterial dissemination to other anatomical places, such as the liver; 
bacteremia and septicemia and the consequent penetration into the brain (Doran and 
Nizet, 2004, Maisey et al., 2008). 
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Figure 1 | Schematic view of the stages of neonatal GBS infection 
 
Approximately 75% of the EOD cases are associated with type Ia, III and V 
serotypes (Nandyal, 2008). Serotype III GBS is the main responsible for the majority of 
infections in neonates worldwide (Edmond et al., 2012).  
In LOD, it has been shown that most cases are associated with a singular 
capsulated serotype III GBS clone, designated as ST-17 (Jones et al., 2003, Lin et al., 
2006, Tazi et al., 2010). The ST-17 clones are referred has being from the hyper-
virulent type (Davies et al., 2004). Around 25-50% of GBS meningitis surviving infants 
experience permanent neurologic sequelae, including mental retardation, cerebral 
palsy, seizure activity, deafness and/or blindness (Edwards et al., 1985, Gibbs et al., 
2004). Yet, these findings are most likely to underestimate the real incidence of GBS-
induced meningitis, as signs of meningitis are often subtle in the neonate and therefore 
difficult to diagnose (Garges et al., 2006). 
 
2.3 Prophylaxis for neonatal GBS Infections 
In 1996, the Centers for Disease Control and Prevention (CDC), in association 
with both the American Congress of Obstetricians and Gynecologist and the American 
Academy of Pediatrics, presented guidelines for intrapartum antibiotic prophylaxis 
(IAP). According to these new measures, all pregnant women between the 35th and 
37th week must be subjected to GBS screening and, whether positive, they are 
administered with IAP. In addition, the guidelines were meant for all the women that 
presented, at time of birth, risk factors of disease transmission (Verani et al., 2010). 
In 2002, these guidelines were reviewed (Schrag et al., 2002a) and, in 
November of 2010, a new CDC document was emitted (Verani et al., 2010). Some key-
points in the combat against GBS disease were reinforced, such as: upgrading and 
improving the laboratorial methods for rapid and more accurate GBS identification, 
change in the penicillin dose used in prophylaxis, alternate antibiotic options for 
penicillin allergic women, actualized IAP and screening algorithms for preterm delivery 
STAGES OF NEONATAL GBS INFECTION
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women, and lastly algorithm improvement for newborn babies with risk of contracting 
EOD (Verani et al., 2010, Schrag and Verani, 2013). 
Such measures were accepted worldwide in developed countries and, although 
they aided the reduction of EOD rates, they did not contributed significantly for the 
lowering of the LOD rates (Verani et al., 2010, Berardi et al., 2013a, Schrag and 
Verani, 2013). Actually, in the period of widespread IAP use, the incidence of invasive 
early-onset GBS disease in Active Bacterial Core surveillance (ABCs) decreased by 
more than 80% from 1.8 cases/1000 live births in the early 1990s to 0.26 cases/1000 
live births in 2010 (Figure2) (Schrag and Verani, 2013). However, GBS meningitis 
among patients under 2 months of age did not change in a significant fashion after the 
introduction of universal GBS screening of pregnant women and improvement in 
neonatal intensive care (Thigpen et al., 2011). Furthermore, the casualties from both 
EOD and LOD remain high and the morbidity associated with LOD has not changed 
substantially over decades (Gibbs et al., 2004) (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 | Incidence of invasive early and late-onset group B streptococcal disease, Active Bacterial Core surveillance, 
United States, 1990–2010 (Schrag and Verani, 2013). 
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3 Meningitis 
 
3.1 Pathophysiology of Meningitis 
Bacterial meningitis is an inflammation of the meninges that affects the pia, the 
arachnoid and the subarachnoid space (Hoffman and Weber, 2009). It is a complex 
mechanism that occurs in a series of steps which include: the adherence of the 
pathogen to the host mucosal surfaces and subsequent colonization; the bacterial 
invasion to adjacent intravascular spaces; and, of course, the survival and 
multiplication inside the host, resulting in bacteremia. Once microorganisms reach the 
bloodstream, they can cross into the subarachnoid space and  they can enter in places 
where the Blood Brain Barriers (BBB) is vulnerable or inexistent, such as the choroid 
plexus (CP) (Daum et al., 1978). In addition, bacteria leaving cerebral capillaries enter 
the cerebrospinal fluid (CSF) and initiate an inflammatory cascade in the subarachnoid 
space (Spellerberg, 2000).  
Although bacteremia is very important for meningitis development, it’s not 
sufficient by itself to microorganism penetration into the Central Nervous System 
(CNS). To cause meningitis, the pathogen must be able to leave the bloodstream and 
cross the barrier that separates it from the CNS. 
 
3.2 Homeostatic Barriers of the Brain 
The CNS is protected at three key sites: the endothelium of brain parenchymal 
blood capillaries, the choroid plexus epithelium and the arachnoid epithelium of the 
meninges (Abbott, 2005). These barriers play critical roles in controlling the movement 
of a series of metabolites, but also drugs, between the blood and the brain (Saunders 
et al., 2013). 
Figure 3 displays the locations of the different homeostatic barriers in the brain, 
with (A) representing the Blood-Cerebrospinal Fluid Barrier (BCSFB); (B) the Blood-
Brain Barrier (BBB); (C) the fetal CSF-Brain Barrier and (D) the Outer-CSF Barrier.  
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Figure 3 | Homestoatic Barriers of the Brain. (A) The blood-CSF barrier between the choroid plexus blood vessels 
and the CSF. (B) The Blood-Brain Barrier between the lumen of the cerebral endothelium and the brain parenchyma. 
(C) The inner CSF-brain barrier, present in only during development, between the CSF and neuroependyma. (D) The 
outer CSF-brain barrier between the subarachnoid space and overlying structures. [Adapted from (Saunders et al., 
2013)]. 
The BBB is a functional and structural barrier which separates the brain 
extracellular fluid (BECF) from the blood in the CNS. As shown in Figure 4, three 
cellular elements of the brain microvasculature compose the BBB: brain microvascular 
endothelial cells, astrocyte end-feet, and pericytes (Kim, 2003, Ballabh et al., 2004). 
The BBB establishes both a physical as well as a metabolic barrier, isolating the 
CNS from systemic circulation and thus creating a unique and stable environment for 
an optimal neuronal activity (Correale and Villa, 2009). Moreover, this structure 
maintains the neuronal microenvironment homeostasis in a biochemical fashion, as 
endothelial cells regulate the molecular traffic in the brain, protecting it from 
microorganisms and circulating toxins in the bloodstream (Kim, 2008). 
Endothelial cells present unique characteristics that make them so efficient in 
their functions of protection. Tight junctions, found between the adjacent cerebral 
endothelial cells, form a diffusion barrier, which selectively excludes most blood-borne 
substances from entering the brain (Ballabh et al., 2004). Furthermore, their cytoplasm 
lacks fenestrations present in most of the peripheral tissues (Correale and Villa, 2009). 
These special features make the BBB virtually impermeable to ions and molecules. In 
addition, the almost inexistent pinocitosis also contributes to the tight control of the 
molecular trafficking (Correale and Villa, 2009).  
While endothelial cells are the main keepers of the brain homeostasis, 
astrocytes and pericytes help maintaining the barrier properties, but their functions are 
not fully understood. Yet, evidence from cell culture studies indicate that astrocytes 
upregulate many BBB features: they tightly sustain the vessel wall and appear to be 
critical for the induction and maintenance of the tight junction barrier (Hayashi et al., 
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1997, Sobue et al., 1999). As for pericytes, they are not believed to function as a 
barrier in the mammalian brain (Ballabh et al., 2004). 
 
 
 
Figure 4 | The blood–brain barrier. The blood–brain barrier is formed by brain microvascular endothelial cells, 
astrocytes and pericytes. It maintains the neural microenvironment by regulating the passage of molecules into and out 
of the brain, and protects the brain from any microorganisms and toxins that are circulating in the blood. 
 
The BCSFB displays fundamentally different properties when compared with 
the BBB, either structurally or functionally (Johanson et al., 2011). The CP operates 
jointly with blood brain barrier, as the choroid epithelial interface on the BCSFB has 
distinctive structural features that facilitate regulatory functions for ultimately promoting 
neuronal environment maintenance. The endothelium in the choroid plexus is 
fenestrated and forms a non-restrictive barrier. In addition, choroid plexus epithelial 
cells are joined by functional tight junctions towards the apical surface that stop the 
movement of hydrophilic molecules (Saunders et al., 2013). Two prominent areas 
where the blood is near the CSF are the arachnoid membrane blanket over the 
subarachnoid space and the CP invagination of the ventricles. The lack of true 
lymphatic capillaries in the inner surface of the brain makes the CSF the main cleanser 
of harmful proteins and anionic catabolites in young adulthood (Johanson et al., 2011). 
Interestingly, inner CSF-brain barrier (Figure 4) is present only during early 
development, between the CSF and the neuroependyma (Dziegielewska et al., 2000). 
In adulthood due to a loss of strap junctions and due to the switch from neuropendyma 
Neuron
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to ependyma, this structure is not present. So, there’s no restriction of molecular 
trafficking in the adult brain across this interface.  
Apart from the described barriers, another barrier plays an important role in the 
regulation of neuronal homeostasis, the outer CSF-brain barrier (Figure 4). This barrier 
is located between the CSF-filled subarachnoid space and overlying structures 
(Saunders et al., 2013). Endothelium is fenestrated and therefore its functions as 
barrier are not the most efficient. On the other hand, outer cells of the arachnoid 
membrane are connected by tight junctions. 
 
3.3 Pathogen Translocation across the Blood Brain Barrier 
Theoretically, all pathogenic microorganisms are able to access the CNS but 
only a small fraction of these pathogens cause infections in the CNS (Kim, 2008). The 
BBB relies on a very complex equilibrium that maintains the neuronal environment 
homeostasis. The microorganism crossing and invasion reflect a series of tight 
interactions between the host and pathogen. Simultaneously, bacteremia and 
consequent bacterial translocation to the BBB (Spach and Jackson, 1999) are also a 
route of CNS infection.  Even though high levels of bacteria are important for meningitis 
development, it is not enough on its own for microorganism entrance in the CNS (Kim, 
2003). 
Microorganisms can bypass the BBB by three different methods [reviewed by 
(Kim, 2006) and (Drevets et al., 2004)]: transcellularly, paracellularly and/or by means 
of infected phagocytes, so called Trojan horse mechanism (Figure 5). Transcellular 
traversal, refers to bacterial entrance thought the cells without tight junction rupture of 
the BBB; it has been demonstrated for several bacterial pathogens, such as E. coli 
(Kim, 2001, 2002, Kim et al., 2003, Kim, 2003), GBS (Nizet et al., 1997), Streptococcus 
pneumoniae (Ring et al., 1998), L. monocytogenes (Greiffenberg et al., 1998), 
Neisseria meningitidis (Unkmeir et al., 2002), and for some  fungal pathogens such as 
Candida albicans (Jong et al., 2001). As for the paracelular mechanism, it has been 
defined as microorganism passage between the endothelial cells of the BBB, with or 
without tight junction destruction. Paracellular penetration of the BBB has been 
suggested for the protozoans Trypanosoma spp. (Grab et al., 2005). Lastly, in the 
Trojan horse mechanism, infected phagocytes carry the pathogen through the BBB and 
into the CNS; this mechanism has been suggested for L. monocytogenes (Join-
Lambert et al., 2005) and Mycobacterium tuberculosis (Drevets et al., 2004). Recently 
our group showed that recruitment of the host plasminogen to the GBS surface 
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generates a proteolytic bacterium that after conversion to plasmin, can traverse the 
BBB (Magalhaes et al., 2013). 
 
 
Figure 5 | Mechanisms involved in microbial traversal of the blood–brain barrier. Pathogens can cross the blood–
brain barrier transcellularly (Transcelullar traversal), paracellularly (Paracelullar traversal) and/or in infected phagocytes 
(the Trojan-horse mechanism). 
 
3.4 GBS Infection and Virulence 
The CNS tropism that some GBS strains present and its ability to invade the 
CNS reflects a series of complex interactions between the host cells and many surface-
associated and secreted bacterial components. Briefly, some GBS molecules, like 
fibrinogen-binding protein A (FbsA) (Tenenbaum et al., 2005), pili A (PilA), (PilB) 
(Maisey et al., 2007), laminin-binding protein (Lmb) (Tenenbaum et al., 2007), β-
hemolysin/cytolysin toxin (β-h/c) (Doran et al., 2003), serine-richrepeat-1 (van Sorge et 
al., 2009), and glycosyltransferase involved in the production of a cell-membrane 
glycolipid anchor for lipoteichoic acid (Doran et al., 2005), mediate interaction of the 
pathogen with brain microvascular endothelial cells (BMEC) and penetration through 
the BBB. Many of these GBS ligands are known to bind to extracellular matrix 
molecules such as fibronectin, fibrinogen and laminin, which successively bind host-
cell-surface proteins such as integrins. It has been recently identified a hypervirulent 
GBS adhesin (HvgA), which significantly impacts on intestinal colonization by 
translocation across the intestinal barrier and mediates adhesion to BMEC (Tazi et al., 
2010). 
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3.5 GBS translocation across the BBB 
Once in the bloodstream, GBS has the ability to cross the BBB and cause 
meningitis. The mechanisms from which GBS establishes CNS infection remain 
unknown. Some studies state that GBS is able to penetrate the BBB through a 
transcelullar mechanism, also described to E. coli (Kim et al., 2003), since GBS was 
observed intracellularly within vaculae connected to human BMEC membranes (Nizet 
et al., 1997). Electron microscopy also shows that GBS migrates through the cell, from 
the apical surface to the basal surface with no sign of free bacteria in the cytoplasm. 
GBS requires the presence of live cells to cross the BBB, as protein and nucleic acid 
synthesis is necessary and also modifications of the cytoskeleton, microtubules and 
microfilaments of the host cell are needed (Huang et al., 2000). However, conducted 
studies in other culture-types, such as respiratory and gastrointestinal epithelium, 
indicate that the bacteria could enter through a paracelullar mechanism, once GBS is 
found between adjacent cells (Pezzicoli et al., 2008). We recently showed that 
hijacking of the host plasminogen system to generate a proteolytic bacterium 
constitutes another mechanism used by GBS to penetrate into the brain (Magalhaes et 
al., 2013) 
 
3.6 Experimental Models of Neonatal Meningitis 
Concerning bacterial meningitis, namely the induced by GBS, there’s a lack of 
clinical data, as sampling procedure is often invasive and complex. The limitation of a 
suitable animal model, essential for a better understanding of the pathogenesis and 
pathophysiology of neonatal meningitis induced by this microorganism could explain 
the worldwide high mortality and morbidity rates caused by GBS infection (Gaschignard 
et al., 2011). Most of the data is derived from severe cases of neonatal meningitis, 
normally associated with death or severe health complications of the studied 
individuals (Brochet et al., 2008). In addition, the current knowledge about the 
pathogenic mechanisms that contribute to CNS complications and neuronal damage 
are largely derived from experimental models of meningitis, either in vitro or in vivo. 
However, none of the experimental animal models developed to date mimic the route 
of infection used by GBS in humans. Although these studies are valuable, as they 
helped to understand some points of this microorganism pathogenesis, they have 
serious limitations and drawbacks, as they bypass the normal bacteremia-meningitis 
sequence of GBS infection (Ferrieri et al., 1980, Mancuso et al., 1994, Leib et al., 1996, 
Reiss et al., 2011, Patterson et al., 2012, Barichello et al., 2013). 
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Therefore, the aim of my project was the characterization of our animal model of 
neonatal GBS infection that uses an approach that addresses human pathogenesis of 
ascending infection of neonates acquired from the lower genital tract of their mothers.  
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Objectives 
 
The main aim was to characterize the suitability of our animal model to the study of 
neonatal meningitis induced by GBS. Thus, in this project the specific aims were:  
• To assess vaginal and gastrointestinal tracts maternal colonization and GBS 
infection on their offspring;  
• To evaluate the meningitis characteristics signs in the brains of the pups born 
from colonized mothers;  
• To evaluate the cognitive and motor performance of the animals that survive to 
GBS infection, in adulthood. 
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Bacterial strains and growth conditions 
GBS strain BM110, capsular serotype III, and MLST sequence type ST-17 is a 
well-characterized isolates from human with invasive infections. GBS BM110 was 
cultured at 37°C in Todd-Hewitt (TH) broth or agar (Difco Laboratories) containing        
5 µg/mL of colistin sulphate and 0.5 µg/mL of oxalinic acid (Streptococcus Selective 
Supplement, Oxoid).  
 
Animals and Ethics statement 
Six- to eight-week-old male and female BALB/c mice were purchased from The 
Jackson Laboratory. All animals were kept at the ICBAS animal facilities during the 
time of the experiments. All procedures were performed according to the European 
Convention for the Protection of Vertebrate Animals used for Experimental and Other 
Scientific Purposes (ETS 123) and 86/609/EEC Directive and Portuguese rules (DL 
129/92). All efforts were made to minimize animal suffering and to reduce the number 
of animals used. 
 
Gestation time and pregnancy monitoring 
Detection of the vaginal plug and measurement of body weight were jointly used 
to determine the time of gestation. Two to three females were put together with one 
male and examined for the presence of vaginal plug every morning. The finding day of 
the vaginal plug was considered as gestation (G) day one (G1) and the pregnancy 
progression was monitored every other day by weighting the females. 
 
Neonatal mouse model of GBS-induced meningitis 
Pregnant BALB/c mice were intra-vaginally (i.vag.) infected at G17 and G18 
with 106 GBS BM110 cells, in a 30 µL volume. This infection period was determined to 
be the optimal, as early infections did not allow pregnancy to reach term (data not 
shown). Pregnant females were allowed to deliver and newborns were kept with their 
mothers during the entire time of the experiment. Survival curves were determined in a 
30-day period. Pups were weaned after postnatal day (PND) 30. To assess bacterial 
colonization, the liver, lungs and brain were aseptically removed at the indicated PND 
and homogenized in PBS. Serial dilutions were prepared in sterile saline, plated on TH 
agar and incubated overnight at 37°C.Blood was collected in heparinized containers 
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and centrifuged to collect the sera. When possible, 10 µL of blood were saved for CFU 
counts. The sera were stored at -80˚C until analysis. At the indicated times, stool 
samples were collected and serial dilutions were plated on selective medium (Granada, 
Biomérieux) for CFU counts. 
 
DNA extraction 
Stool Samples 
Stool samples were placed in 200 µL pre-heated PBS and subsequently 
homogenized. Samples were centrifuged, 2 min, at 8000 rpm (Biofuge Fresco, 
Heraeus Instruments) and the supernatant was rejected. The pellet was resuspended 
in 150µL in TE (Tris 10 mM, EDTA 1 mM) solution and centrifuged, 10 min, at        
8000 rpm. The supernatant was discarded and the pellet resuspended in 150 µL of TE-
Sucrose (Tris 10 mM, EDTA 1 mM, 7% Sucrose) solution. 60 µL of Lysozime (Sigma) 
(10 ng/mL) were added and incubated for 1h, in water bath, at 56ºC, with periodical 
shaking. 36 µL of EDTA (Merck) 0.25 M+ 24 µL SDS 10% (Sigma) solution was added 
and the solution was resuspended several times. 40 µL of Proteinase K (Affimetrix)      
(5 mg/mL) were added, gently mixed and incubated during 30 min at 37ºC (until 
solution appeared clear). 27µL of NaCl (Merck) 5 M was added and gently mixed.    
37.5 µL of CTAB (previously heated) was added and incubated for 20 min at 65ºC. 
Genomic DNA was obtained through Phenol-Chlorophorm (Sigma) extraction. Samples 
were centrifuged and the aqueous phase was transferred to a new tube and 
precipitated in isopropanol (Merck) and shaken until a DNA precipitated was formed. 
Thereafter, 0.5 mL of ethanol (Sigma) was added, samples were centrifuged, the 
supernatant was discarded and DNA was rehydrated in 50 µL of DNA-Hydration 
Solution (Qiagen). 
 
PCR assays 
The cfb gene encoding the Christie-Atkins-Munch-Petersen (CAMP) factor is 
virtually present in all GBS isolates, and therefore is suitable for PCR detections 
(Wilkinson, 1977). The GBS cfb gene (CAMP factor) was amplified from the extracted 
genomic DNA. Specific primers were used in the PCR assay: Sag59 (T T T C A C C A G C T G 
T A T T A G A A G T A) e Sag190 (G T T C C C T G A A C A T T A T C T TT G A T) (Ke et al., 2000). 
Escherichia coli K1 was used as a negative control.  In addition, purified GBS genomic 
DNA was used as a positive control. MyTaq HS Red Mix (Bioline) and ultrapure H20 
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(Gibco) were used in the PCR mix. MWG Biotech thermocycler was used according 
with Table 2. 1.5% ultra-pure agarose (Life Sciences) gel electrophoresis was 
performed to analyze amplification products. 
 
Table 2 |GBS-specific conventional PCR assay characteristics. 
 Cycles Temperature(˚C) Time 
Denaturation 1 94 3 min 
Amplification 40 
95 1 seg 
55 30 seg 
72 2 min 
Storage -- 8 ∞ 
 
Histopathology 
Brain sections were fixed in 10% buffered formalin, routinely processed, and 
embedded in paraffin. 4-5 µm-thick sections were cut and stained with hematoxylin and 
eosin (H&E). 
 
Behavioral assessments 
The mice that survived to GBS-induced meningitis were evaluated to determine 
their cognitive and motor performance. The behavioral tests were performed in a sound 
attenuated, temperature (21 ± 1ºC) and humidity (70%) controlled room with a 12-h 
light–dark cycle (lights at 7 a.m.), using male animals at PND60 (begin of adulthood), 
from different litters. The animals were kept at approximately 90% (26.64 ± 1.28 g) of 
their free feeding body weight and began training after reaching this weight. During the 
whole test time mice had restricted access to food (they were only fed following testing) 
and their weight and general health were carefully monitored every day to prevent 
more than a 10% body weight loss. 
 
Radial maze test 
The cognitive status of the animals as regards spatial learning and memory was 
assessed with the 8-arm radial maze. Working and reference memory were assessed 
simultaneously through a fixed position reward task, in which half of the arms were 
baited and their positions were fixed throughout the training trails. The radial maze 
consists in a central area (22 cm in diameter) giving access to eight equally-sized arms 
in transparent acrylic (length, 25 cm; width, 6.5 cm). Identical food wells (2.5 cm deep 
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and 3 cm in diameter) were placed at the distal end of each arm. Commercialized 
sugar pellets (Bioserv F0042 - DPP'S 45MG SUGAR 50TH) located at the end of each 
baited arm were used as rewards. Two days prior to the beginning of the test, the 
rewards were placed once a day in the animal cages, to allow them to explore and eat 
the pellets. There were extra-maze clues including free-standing laboratory equipment, 
and geometric pictures in walls to help mice navigation. A digital stopwatch was used 
to record the amount of time taken to a mouse to complete a trial. 
Habituation/training - On the first habituation day, each animal was placed alone 
in the center of the starting platform and allowed to freely explore the maze. On the 
second habituation day, the mice were allowed to explore the apparatus with randomly 
placed food pellets throughout the maze, for a 5 min period. On the third habituation 
day, the food pellets were placed at the distal end of each arm and the animals were 
allowed to explore for 5 min. The habituation period ended after the mouse ate at least 
four rewards or when 5 min had elapsed. 
Test – During the test phase, four out of eight arms were baited and randomly 
assigned for each mouse, but always constant for the same animal throughout the trial 
period, and the mice were given a maximum of 5 min to complete the maze. 
Geometrical figures placed on the walls and the researcher were the only visual extra 
maze cues present. In each training session, the mouse was placed within a 
transparent cylinder on the platform in the middle of the maze for few seconds. The 
cylinder was then lifted and the animal was allowed to move freely in the maze. It was 
considered that an animal had entered an arm when the four paws and the tail were 
inside it. Trials ended when the animal had either eaten all four rewards or 5 min had 
passed, whichever came first. Once the animal returned to the central platform and the 
cylinder was lowered; a minute later the next trial took place. One session of two trials 
was performed per day over fourteen days. The maze was rotated and wiped with a 
dextran solution at 2% between animals to eliminate or reduce olfactory cues from 
different individuals.  
Behavioral analysis - There were four measures used in behavioural analysis. 
The number of errors made: working memory error, defined as re-entering an arm 
already visited within a trial; and a reference memory error, defined as entering a never 
baited arm. Trial completion time was also included. It started when the cylinder was 
lifted, in which the mouse had full access to explore the maze, and stopped when the 
animal entered the fourth baited arm. Response latency was also measured and 
defined by the total session duration divided by the number of arms entered (seconds 
per entry). Seven blocks were calculated by average measure of four trials per day. 
FCUP 
Characterization of an experimental model of neonatal meningitis induced by Group B Streptococcus 
27 
 
 
Open field (OF) 
Exploratory behavior and general locomotor function were assessed in the open 
field. In each session, the mice were placed in the center of the open-field arena (40 x 
40 x 40 cm). The OF arena is divided virtually into 16 equal squares, via a 4 x 4 grid to 
assist with data analysis. Each session on the OF was registered for 5 minutes. All 
trials were recorded by a video camera (SONY DCR-SF 290), suspended above the 
test arena, and analyzed afterwards using the software package Observer XT 7.0 
(Noldus Information Technology). The following parameters were assessed: total 
distance walked, frequency and time spent in center or periphery section of the OF. 
The number of rears (i.e. rat reared on its hind paws, both on or off the walls), arena 
exploration and time spend unmoved were also scored. The apparatus was cleaned 
between subjects with a solution of 2% dextran. 
 
Neurotransmitter Determination 
After the completion of behavioral studies, mice were euthanized by 
decapitation and the brains rapidly dissected on ice, frozen on dry ice and stored at       
-80°C until neurochemical analysis. Amino acid levels and the levels of monoamines 
and their metabolites were measured by high performance liquid chromatography, 
combined with electrochemical detection (HPLC/EC), using a Gilson instrument 
(Gilson, Inc., Middleton, WI, USA) (Alves et al., 2009). 
Amino acids 
For gamma-aminobutyric acid (GABA) and glutamate, the prefrontal cortex, 
hippocampus, striatum and cerebellum were used. The day before the neurochemical 
determination, tissues were thawed, and homogenized in 200 µL of ice-cold 150 mM 
potassium buffer with phosphoric acid, through ultrasonication (Sonifier W-250, 
Branson Ultrasonics) and centrifuged at 16,000 g, for 10 min at 4ºC. The supernatant 
was collected, diluted 1:2 in dilution solution (0.4 N perchloric acid, 0.4 mM sodium 
dissulfite, 0.9 mM EDTA), filtered thought a 0.2 µm nylon microfilter (Corning) at  
16,100 g for 5 min, at 4°C, and stored at -20°C overnight. Afterwards, samples were 
derivatized by adding 100 µl of NaOH 0.1N and 15 µl OPA (10 mg/mL of OPA, 45.4 M 
sodium sulphite, 4.5% absolute ethanol in 327 mM borate buffer at pH 10.4) to 50 µL of 
sample. Samples were allowed to react at room temperature in the dark, for 10 min and 
then injected into the HPLC system. The mobile phase consisted of 0.06 M sodium 
dihydrogen phosphate, 0.06 mM EDTA and 20% methanol, pH adjusted to 4.4 with 
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Phosphoric acid and it was filtered and degassed. The flow was maintained at           
0.8 mL/min. Concentrations of GABA and glutamate were calculated using a standard 
curve generated with a glutamate and GABA standard (Sigma-Aldrich). Final results 
were expressed in terms of amino acid content per amount of protein. 
 
Monoamines and their metabolites 
Levels of norepinephrine (NE), epinephrine (E), dopamine (DA), 3,4-
diydroxyphenylacetic acid (DOPAC), 5-hydroxyindoleacetic acid (5-HIAA), serotonin (5-
HT) and homovanillic acid (HVA) were determined in the striatum, prefrontal cortex, 
hippocampus and amygdala. The different brain regions were ultrasonicated in 200 µL 
of ice-cold 0.2 M perchloric acid and centrifuged at 13,000 rpm for 3 min at 4 °C. The 
supernatant was then collected and filtered as described above. Aliquots of 120 µL 
were injected into the HPLC system, using a mobile phase of 70 mM of potassium 
phosphate monobasic buffer (pH adjusted to 3.0 by adding phosphoric acid) in 10% 
(v/v) of methanol, 1 mM 1-heptanosulfonic acid and 107.5 mM Na-EDTA. The flow was 
maintained at 0.8 mL/min. Concentrations of neurotransmitters were calculated using 
standard curves generated with standard monoamines (Sigma). Final results were 
expressed in terms of monoamine content per amount of protein. 
 
Total protein determination 
Protein content was determined using the BCA Protein Assay Kit (Thermo 
Scientific-Pierce). Briefly, bovine serum albumin (BSA) was used as a standard protein 
(0.01– 0.5 mg/mL). 10 µL of sample or BSA standard in duplicate were loaded into a 
microplate and added 200 µL of working reagent to each well. After 30 min incubation 
at 37ºC, absorbance was read at 562 nm using a microplate reader. 
 
Statistical analysis 
All graphs were generated using GraphPad Prism software (GraphPad 
Software). Means and standard errors of the means (SEM) were calculated. Survival 
studies were analyzed with the log-rank test and bacterial counts were analyzed using 
Mann-Whitney U test. The data from radial maze test were submitted to analyses of 
variance (ANOVA) with repeated measures for block sessions. Each block-session was 
calculated by average measure on four successive trials. For statistical analysis of 
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open-field data a one-way ANOVA was used, followed by Tukey post-hoc 
comparisons, when appropriate. Student’s unpaired t test was used to analyze the 
differences between groups, when appropriate. A P value of < 0.05 was considered 
statistically significant. 
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1 Vaginal and gastrointestinal tracts of the female mice 
remains colonized with GBS after delivery 
It is known that GBS transmission to newborns usually occurs during the labor by 
aspiration of contaminated fluids present in the vaginal mucosa. Taking into account, 
pregnant BALB/c female mice were infected intra-vaginally with 5x105 CFU of GBS 
BM110, a serotype III GBS hypervirulent strain ST-17, responsible for the 
overwhelming majority of neonatal meningitis (Jones et al., 2003). 
The 17th and 18th gestational days were defined as the specific window of 
intervention for intra-vaginal inoculation of the bacterium and the vaginal colonization 
was assessed by plating the vaginal washout several times after the delivery. Because 
the excess of blood and bodily fluids at delivery day made the procedure very difficult, 
this day was excluded from evaluation. As shown in Figure 6A, all the females 
remained highly colonized until day four after birth. After this day, the bacterial loads 
started to decrease and by day 10, no GBS was detected. Since the gastrointestinal 
tract is a reservoir of GBS, the bacterium was also searched in the feces of these 
female mice. PCR assays with specific GBS-primers (Ke et al., 2000) were used to 
search for GBS in the feces. As shown in Figure 6B, GBS was found in their feces, 30 
days after birth indicating that the bacterium colonized the gastrointestinal of these 
females.  
 
 
 
Figure 6 | Colonization of the murine vaginal mucosa with GBS. Pregnant BALB/c mice were intra-vaginally infected 
with 5x105 CFU of GBS BM110, at the 17th and 18th gestational day. (A) Upon birth, the number of GBS colony-forming 
units (CFU) in vaginal tract was determined, by vaginal washouts with PBS. Data are the mean (n=20)  of 10 
independent experiments ± SEM. (B) Conventional PCR assay for the detection of GBS (153-bp amplicon) in anal 
specimens from BALB/c female mice. Lane 1 shows a 100 bp ladder molecular-size standard. Lanes 2, 3 and 4 
samples collected 30 days after delivery. Lane 5 and 6 shows positive and negative controls, respectively. 
A B
34 FCUP 
Characterization of an experimental model of neonatal meningitis induced by Group B Streptococcus 
 
2 GBS is vertically transmitted to the progeny  
The survival rates of mice born from infected females were evaluated and as 
shown in Figure 7, approximately 40% of the offspring died after birth with 14% dying 
within the first 24h after birth. After day four, no more deaths were registered.  
 
 
 
Figure 7 | Murine model of neonatal GBS-induced meningitis. Pregnant BALB/c female mice were intra-vaginally 
infected with 106 CFU of the ST-17 hyper virulent strain BM110, in the 17th and 18th gestational days. Kaplan-Meier 
survival curves of neonatal mice born from intra-vaginally infected dams, monitored during a 7 days period. The 
numbers between parentheses represent the number of animals that survive versus the total number of infected 
progeny. Results represent data pooled from ten independent experiments. 
 
The bacterial load was assessed in key organs such as the lungs, the liver, 
blood and brain at the indicated post natal days (PND). As shown in Figure 8A, 
newborn mice presented high and sustained level of GBS in the lungs, up to one week 
after birth. Moreover, GBS was also detected in the blood of infected pups reaching a 
maximum level at PND1, decreasing daily afterwards and by PND7 bacteria were no 
longer detected (Figure 8B). In addition to the presence of GBS in the bloodstream of 
infected pups, the liver was also used to search for GBS and the results showed that 
bacterial load was detected from PND1, decreasing until it and at PND14 was no 
longer detectable (Figure 8C). Interestingly, GBS was also found in the brain of these 
animals (Figure 8D) reaching the highest colonization at PND4. This last data showed 
that GBS traversed the BBB and reached the central nervous system, causing 
infection. 
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Figure 8 | Murine model of neonatal GBS-induced meningitis. Bacterial counts of GBS in lungs (A), blood (B), liver 
(C), and brain (D) of neonatal mice at different time points after birth. Data points are shown as the mean (n=16) pooled 
from 3 independent experiments ± SEM. 
 
3 Brain histopathological changes in GBS infected neonates 
To further analyze the brain of infected pups, histopathological analysis was 
performed. All infected pups exhibited some clear hallmarks of meningitis: meningeal 
detachment, edema, venous congestion, and signs of hemorrhage (Figure 9). These 
histological features are in accordance with those observed in humans. Moreover, 
influx of inflammatory cells was also observed in the brains of GBS-infected pups, 
when compared to age-matched control animals. These results are indicative that our 
murine model of neonatal meningitis mimics the vertical transmission of infection 
similarly to the observed in humans. 
0 2 4 6 8 10 12 14
0
1
2
3
4
5
Lungs
lo
g 1
0 
CF
U 
/ o
rg
an
0 2 4 6 8 10 12 14
0
1
2
3
4
5
Blood
lo
g 1
0 
CF
U 
/ B
lo
o
d
A B
Days afterbirth Days after birth
0 2 4 6 8 10 12 14
0
1
2
3
4
5
Liver
lo
g 1
0 
CF
U 
/ o
rg
an
C
Days afterbirth
0 2 4 6 8 10 12 14
0
1
2
3
Brain
lo
g 1
0 
CF
U 
/ o
rg
an
Days after birth
D
36 FCUP 
Characterization of an experimental model of neonatal meningitis induced by Group B Streptococcus 
 
 
Figure 9 | Murine model of neonatal GBS-induced meningitis. Histopathology of brain tissues of representative 
individual pups infected with GBS compared with non-infected control, after staining with H&E. Arrows indicate 
meningeal detachment, edema, and venous congestion. Magnification, 40x. 
 
4 Mice survive to neonatal GBS infection present behavior 
alterations in adult life 
Cognitive and motor performance of the offspring that survived to GBS infection 
was performed in adult life to assess whether they presented neurological sequelae, as 
it has been described in humans. 
4.1 Memory and learning performance 
The outcome of GBS infection on learning and memory performances were 
verified by testing their ability to learn a given task in the radial arm maze apparatus. 
Differences among the two studied groups, age-matched non-infected controls and 
GBS-survivors, were observed when comparing the first session with the last one 
(Figures 10A-B). In the control group, a significantly decreased average errors over the 
days were observed, indicating learning. In contrast, the number of working and 
reference memory errors in the GBS-survivors was not significantly different over the 
days, meaning that they were unable to learn the task. Moreover, there were significant 
differences among the groups concerning to latency to enter in the first arm in the first 
four block sessions (Figure C). GBS-survivors showed meaningful slower arm choices 
responses than non-infected controls. 
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Figure 10 | Effects of neonatal GBS-induced meningitis on learning and memory performances in adulthood. 
Pregnant BALB/c female mice were intra-vaginally infected with 106 CFU of the ST-17 hyper virulent strain BM110, in 
the 17th and 18th gestational days. Offspring that survived to infection, or non-infected controls, were examined by their 
ability to execute tasks in the radial arm maze at PND60. Number of reference (A) and working (B) memory errors, and 
latency (C) in the radial arm maze task. The data represent the mean ± SEM. *, P < 0.05. 
 
4.2 Motor performance 
To assess whether the increase latency was associated with reduced mobility, 
the mice were subjected to the open field test (OFT). The OFT is widely used to 
evaluate the mice’s natural exploratory behavior and general motor function, as it 
opposes the mouse’s innate curiosity to explore a unknown area with the fear of wide-
open spaces (Stanford, 2007). Figure 11 illustrates the total distance covered by the 
two mouse groups, GBS-survivors travelled significantly less when compared with age-
matched controls. Moreover, Figure 11 shows the overall activity of GBS-survivors, 
revealing that these animals spent significantly more time in the periphery compared 
with non-infected controls. Also, these animals present a decreased central ambulatory 
activity comparatively with age-matched controls. The frequency in movement, either 
into the periphery or towards the center area was significantly decreased in the GBS-
survivors group (Figure 12A and 12B). Also, when analyzing the exploratory activity of 
GBS-survivors, the results showed that this group of animals had a meaningful higher 
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immobility and frequency when compared with age-matched controls (Figure 12D). In 
addition, exploratory vertical rearing of the mice was also assessed, and Figure 12C 
shows that the GBS-survivor group spent significantly less time rearing compared with 
non-infected animals. 
 
Figure 11 - Effects of neonatal GBS-induced meningitis in the locomotor and exploratory behaviors in 
adulthood, distance travelled in OFT. Pregnant BALB/c female mice were intra-vaginally infected with 106 CFU of the 
ST-17 hyper virulent strain BM110, in the 17th and 18th gestational days. Offspring that survived to neonatal GBS 
infection, or non-infected controls, were tested in an open field (OF) apparatus at PND60.  
 
 
 
Figure 12 | Effects of neonatal GBS-induced meningitis in the locomotor and exploratory behaviors in 
adulthood. Pregnant BALB/c female mice were intra-vaginally infected with 106 CFU of the ST-17 hyper virulent strain 
BM110, in the 17th and 18th gestational days. Offspring that survived to neonatal GBS infection, or non-infected controls, 
were tested in an open field (OF) apparatus at PND60. (A-B), frequency and time spent in the periphery and center of 
OF maze; (C-D) frequency and time of exploratory behavior. Data are the mean ± SEM, *P<0.05; **P<0.001. 
Control GBS-Survivors
0
1000
2000
3000
4000
*
D
is
ta
n
c
e
 
tr
a
v
e
l (c
m
)
rearing unmoved
0
10
20
30
40
50
Control
GBS-Survivors
*
*
B
e
ha
v
io
r 
du
ra
tio
n
Ti
m
e
 
/ s
e
c
o
n
ds
Center Peripheral
0
10
20
30
40
50
control
GBS-Survivors
* *
B
e
ha
v
io
r 
a
c
tiv
ity
 
fr
e
qu
en
c
y
Center Peripheral
0
50
100
150
200
250 control
GBS-Survivors
*
*
B
e
ha
v
io
r 
a
c
tiv
ity
 
Ti
m
e
 
/ s
e
c
o
n
ds
A B
C D
re
ar
ing
 
ex
plo
ra
tio
n
un
m
ov
ed
0
20
40
60
80 Control
GBS-Survivors
**
**
**
B
e
ha
v
io
r 
fre
qu
e
n
c
y
FCUP 
Characterization of an experimental model of neonatal meningitis induced by Group B Streptococcus 
39 
 
 
Rearing and exploratory frequency were analyzed as an index of investigative 
behavior, and GBS-survivors present a significantly decrease in rearing and exploration 
activities comparatively to non-infected controls.  
All these results showed that the locomotor and exploratory abilities of GBS-
survivors were decreased. 
 
5 GBS-induced meningitis leads to an altered 
neurotransmitter pattern 
To further confirm the differences in the behavioral profile of the GBS-survivors 
group, the levels of the neurotransmitters (amino acids and monoamines) were 
quantified and interpreted to see whether they could explain such behaviors. Thus, 
several brain areas were submitted to a HPLC-ED analysis, namely brain sections 
related with memory acquisition, learning and motor activity. 
5.1 Amino acid quantification 
For amino acid quantification both glutamate and gamma-aminobutyric acid 
(GABA) were analyzed in the hippocampus, thalamus, cerebellum and pre-frontal 
cortex. Concerning the glutamate concentration in the hippocampus, a significant 
decrease in its levels was observed in the GBS-survivor group when comparing with 
the non-infected controls (Figure 13), which supports the behavioral tests in the radial 
maze arm.  
 
 
Figure 13 | Effects of neonatal GBS-induced meningitis in glutamatergic function. Pregnant BALB/c mice were 
intra-vaginally infected with 106 CFU of the ST-17 hyper virulent strain BM110, in the 17th and 18th gestational days. 
Levels of Glutamate in the hippocampus and in the thalamus of the offspring that survived to neonatal GBS infection, or 
non-infected controls, were determined by HPLC-EC, at PND60. Relative levels are shown and normalized to total 
proteins. Data are the mean + SEM, from 8 mice per group. *P<0.05; **P<0.001 
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In addition, the levels of glutamate in the thalamus are also decreased in the 
GBS-survivor animals (Figure 13), which could probably explain the motor deficits 
observed in the OFT. Glutamate levels in the cerebellum and in the pre-frontal cortex 
did not present differences (data not shown). The levels of GABA in the different brain 
sections did not show significant differences (data not shown). 
 
5.2 Monoamine Quantification 
Several monoamine neurotransmitters: epinephrine, norepinephrine, dopamine 
(DA), serotonin and both their metabolites were quantified in hippocampus, striatum, 
pre-frontal cortex and amygdala. When observing the hippocampus of GBS-survivors, 
the levels of the neurotransmitter DA were significantly decreased compared with non-
infected controls (Figure 14A). Accordingly, the levels of the DA metabolite,              
3,4-dihydroxyphenilacetic acid (DOPAC), were also significantly decreased in the 
hippocampus of GBS-survivors (Figure 14B). Homovallinic acid (HVA) levels although 
analyzed, they were below the detection limit (data not shown). 
 
 
Figure 14 | Effects of neonatal GBS-induced meningitis in dopaminergic function in the hippocampus. Pregnant 
BALB/c female mice were intra-vaginally infected with 106 CFU of the ST-17 hyper virulent strain BM110, in the 17th and 
18th gestational days. Levels of DA (A), and DOPAC (B) in the hippocampus of the offspring that survived to neonatal 
GBS infection, or non-infected controls, were determined by HPLC-EC, at PND60. HVA levels were below the detection 
limit (data not shown). Relative levels are shown and normalized to total proteins (A-B). Data are the mean + SEM, 
relative to total proteins. *P<0.05. 
  
The levels of DA neurotransmitter in striatum were slightly lower in the GBS-
survivor than in controls animals, with no significant differences (Figure 15A). DOPAC, 
A significant decrease of DOPAC in the striatum of GBS-survivors were observed 
(Figure 15B). The same tendency is observed with HVA, another DA metabolite, as it is 
significantly decreased in the GBS-survivor animals Figure 15C. 
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The levels of DA and its metabolites were also analyzed in the pre-frontal cortex 
and in the amygdala, but no significant differences were obtained (data not shown). 
Moreover, the levels of epinephrine, norepinephrine, serotonin (5-HT) and its 
metabolite 5-hydroxyindoleacetic acid (5-HIAA) were analyzed in all brain sections, but 
no significant differences were observed (data not shown). 
 
 
Figure 15 | Effects of neonatal GBS-induced meningitis in dopaminergic function in the striatum. Pregnant 
BALB/c mice were intra-vaginally infected with 106 CFU of the ST-17 hyper virulent strain BM110, in the 17th and 18th 
gestational days. Levels of DA (A), DA metabolites DOPAC (B) and HVA (C) in the striatum of the offspring that 
survived to neonatal GBS infection, or non-infected controls, were determined by HPLC-EC, at PND60. Relative levels 
are shown and normalized to total proteins (A-C). Data are the mean + SEM, from 8 mice per group. *P<0.05. 
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Discussion 
Central nervous system infections, namely meningitis, continue to be an 
important cause of morbidity and mortality throughout the world. Indeed, bacterial 
meningitis is still one of the top ten causes of infection-related deaths worldwide 
(Scheld et al., 2002). Group B Streptococcus is the leading causative agent of bacterial 
meningitis, accounting for 86.1% of cases among those less than 2 month of age 
(Schrag, 2011). The incomplete understanding of GBS-induced meningitis 
pathogenesis is the one important contributing factor for the high rates of mortality and 
morbidity associated with this disease worldwide. 
Clinical data concerning neonatal meningitis cases are scarce and arduous to 
obtain, as newborn babies are very difficult to diagnose correctly. In addition, the 
sampling methods related with meningitis diagnosis are, in most cases, invasive and 
uneasily procedure, causing pain and discomfort to patients. Apart from all, the few 
available meningitis data concerning humans is derived from serious cases of 
infections and worse yet, it is often obtained from fatal cases (Brochet et al., 2008). 
Therefore, it is easy to understand that most of the meningitis related data is attained 
from cell culture assays, in vitro and from experimental animal models, in vivo.  
When searching in the literature, we can find a wide range of experimental 
GBS-induced meningitis models, using different animals as models, such as rats 
(Reiss et al., 2011), mice (Mancuso et al., 1994) or more recently the zebra-fish 
(Patterson et al., 2012). However, all these models use routes that do not address the 
human pathogenesis of ascending infection to neonates, as they bypass the normal 
bacteremia-meningitis sequence (Ferrieri et al., 1980, Mancuso et al., 1994, Leib et al., 
1996, Barichello et al., 2013). One particular example is the study from Reiss and his 
colleagues at 2011, where GBS meningitis was induced through intracisternal injection, 
directly into the brain of 7 and 11-day old rats (Reiss et al., 2011). Not only the infection 
route is artificial, but also the age of the animal is not the most appropriated, as 7 and 
11-day old for rats are no longer considered in the neonatal period.  Regardless the 
stated drawbacks, these models contributed in a very important matter for the scientific 
advances in this area.  
Therefore, the development of an experimental model of GBS-induced neonatal 
meningitis that mimics the human routes of GBS infection is of great importance. Such 
model will help to understand in a more profound way, the mechanisms whereby GBS 
can cause disease. This kind of insight will be very valuable for the development of 
scientific knowledge and also for the discovery of new therapeutic approaches. 
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In our experimental model, pregnant dams were infected intra-vaginally with 
GBS. It is known that GBS-mediated infection in human neonates usually occurs during 
passage through the vagina at birth. Figure 6A shows that female mice infected with 
GBS intra-vaginally remained highly colonized until day 4 after delivery. This showed 
that GBS is present in the vaginal tract of pregnant dams whilst the moment of birth 
ensuring that all neonatal mice contacted with the bacterium through infected mucosa. 
The data regarding the survival rates of the infected offspring in our neonatal 
model showed that approximately 40% of the progeny died from GBS infection (Figure 
7). Interestingly, the percentage of death observed in these pups is similar to what had 
been observed in human babies, prior to the implementation of IAP preventive 
measures (Phares et al., 2008).  
GBS was found in the gastrointestinal tract of healthy individuals, as female 
mothers were positive for GBS in the gastrointestinal tracts by PCR analysis of their 
feces 30 days after birth (Figure 6B). This data sustains the idea that the 
gastrointestinal tract acts as a reservoir for GBS and so its prevalence in the rectum 
higher than in the vaginal tract (Schuchat, 1998). It has been described that the 
gastrointestinal tract acts a reservoir for GBS, and therefore it is the most likely source 
of vaginal colonization in humans (Dillon et al., 1982, Hoogkamp-Korstanje et al., 
1982). Bacteria colonizing the gastrointestinal tract can migrate to other mucosal sites, 
in particular to the vaginal tract of pregnant women (Meyn et al., 2009). Based upon 
these new developments, universal screening and GBS sampling was set off to a new 
method, as combined samples of rectal and vaginal swabs are nowadays used (Block 
et al., 2008). Actually, a study suggests that the intestinal gateway might be involved 
for the initiation of LOD (Tazi et al., 2010). This is supported by the data that 60% to 
40% of human babies are asymptomatically colonized with GBS at birth, and remain 
positive for those bacteria in the rectal tract for several weeks (Weindling et al., 1981). 
 In human babies, the main gateway to GBS infection is thought to be the lungs, 
as contaminated vaginal fluids can be aspirated during birth (Doran and Nizet, 2004). 
Accordingly, in our model, newborn mice had sustained levels of GBS in the lungs 
(Figure 8A), until one week after birth. Moreover, GBS were also found in the blood of 
newborn mice (Figure 8B) which indicates that GBS is able to cross the alveolar-
capillary barrier and consequently access directly into the bloodstream. To confirm the 
systemic infection, liver was also analyzed and, as shown in Figure 8C, the livers of the 
offspring of infected mothers are colonized with GBS.  
To cause CNS infections, pathogens have a long way to travel, as they must 
not only cross lung epithelial barriers and reach the bloodstream, but also gain access 
to the brain and thus to the CNS (Kim, 2006). Our experimental model shows that 
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bacteria were found in the brain of the pups born from colonized mothers (Figure 8D). 
This result indicates that GBS was able to traverse blood-brain barrier and reach the 
central nervous system, has it observed in humans. Moreover, meningitis hallmark-like 
features were displayed in histopathological brain slides, as GBS-infected pups 
presented meningeal detachment, edema, venous congestion, and signs of 
hemorrhage (Figure 9B). All these histological features are consistent with those 
described in human patients. In addition, an influx of inflammatory cells was also 
observed in the brain of the pups born from colonized mothers when compared with 
pups born from non-colonized mothers (Figure 9A). Even though no evidence of 
bacteria inside the brain parenchyma, it is known that brain damage is not necessarily 
caused by the direct entrance of bacteria into the brain (Hoffman and Weber, 2009). 
Actually, meningeal inflammation per se can be sufficient to explain morphological 
differences as the ones observed in our experimental model.  
All of the above results show that our murine model of GBS-induced meningitis 
mimics the course of human pathogenesis of vertical transmission from mother to her 
offspring. 
Even though the IAP measures were important to decrease the numbers of 
EOD, the cases of LOD remain unaltered (Schrag and Verani, 2013). Actually, up to 
50% of the GBS LOD-survivors later on their lives are likely to experience a series of 
long-term neurological sequelae, including learning and memory disabilities (Edwards 
et al., 1985). To confirm whether some of the observed neurological sequelae in 
humans were also observed with mice from our experimental model, behavioral studies 
were conducted with non-infected controls and GBS-survivor mice. Interestingly, 
marked differences between the two animal groups were observed. GBS-survivor 
group presented overall inferior performance results both in the radial-arm maze and in 
OFT. Indeed, in the radial maze test, non-infected controls display a decrease in the 
number of errors committed, whereas GBS-survivors exhibited learning difficulties, as 
their number of working memory errors does not decrease significantly during the 
whole session period (Figure 10A). 
A similar trend is also observed when concerning the reference memory, as 
GBS-survivors commit more errors than the non-infected control group showing a clear 
difficulty on learning (Figure 10B). Moreover, when assessing the motor condition of 
these GBS-survivor animals through the OFT, overall exploratory and locomotor 
abilities were significantly decreased. Indeed, GBS-survivors spent more time without 
moving (Figures 12A-D) or when moved, they spent it on the periphery, a synonym for 
latency (Figure 12B) than the non-infected group. One could also interpret the previous 
results as anxiety signs, and even though OFT can be used in the context of anxiety 
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studies, further and more suitable tests are needed to confirm this hypothesis. Overall, 
our behavior results are in accordance with the described outcomes of GBS-induced 
meningitis in humans. A recent study showed that in spite of the reduced mortality, 
serious long term sequelae result from GBS-LOD. This report was in accordance with a 
paper from 1985, as data showed interesting similarities. Both these studies displayed 
data from GBS-induced meningitis survivors, all of them evaluated at the age of 6, and 
from this group, one half presented global or mild-to-moderate mental retardation, from 
which learning disabilities, and language deficits with associated neurological 
abnormalities. In a 2001 prospective study from England and Wales in 1996-97, 
neonates surviving until the age of 5 presented: cerebral palsy (8.1%), learning 
disability (7.5%), seizures (7.3%) and hearing problems (25.8%). In addition, the same 
study stated that severe disability was significantly more common in infants with GBS-
induced meningitis when compared with other meningitis-inducing pathogens (Bedford 
et al., 2001). 
Since GBS-survivors presented inferior performance in the behavioral tests, 
next we tried to understand whether differences in the neurotransmitter pattern could 
explain the behavioral profile observed. For that purpose, amino-acid and monoamines 
levels were analyzed in different brain sections associated both with learning and 
memory acquisition and motor control. Glutamate is the primary excitatory 
neurotransmitter in the mammalian CNS as it is crucial for learning and memory 
formation. Figure 14 shows that GBS-survivors present decreased levels of glutamate 
in the hippocampus, which could explain the difficulties observed in task learning 
(Figure 10). The hippocampus is involved in spatial processing, memory formation, 
cognitive function and mood regulation (Riedel and Micheau, 2001), thus its functional 
impairment may be reflected in a series of learning and memory disabilities found in 
children that survive meningitis. Learning, memory and neural plasticity depend on 
highly regulated patterns of neuronal activity, which are tightly controlled in time and 
space. When a disturbance occurs, it triggers an unbridled, unregulated and excessive 
neuronal activation, resulting in function impairment. The immune system, when 
working properly, that is, when tightly controlled, plays a crucial role in learning, 
memory, neural plasticity and neurogenesis, as cytokines have a modulatory effect on 
neuronal tissue [reviewed in (Yirmiya and Goshen, 2011)]. For instance, interactions 
between T cells and neurons in the hippocampus are important for memory 
consolidation; the high frequency stimulation-induced IL-1production plays a facilitator 
role in the development of the increased excitability that characterizes Long Term 
Potentiation (LTP), among others (Bliss and Collingridge, 1993). LTP is thought to be 
the main responsible cellular mechanism for learning and memory formation and it is a 
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long-lasting enhancement in signal transmission between two neurons, resulting from 
synchronous stimulation (Teyler and DiScenna, 1987). However, in a context of 
infection, when there’s a higher production of pro-inflammatory cytokines, hyper-
excitability of neuronal circuits can lead to seizures, excitotoxicity and 
neurodegeneration (Allan and Rothwell, 2001). For example in very young individuals, 
such as neonates, in which the brain is more plastic and the large number of newly 
generated neurons are more excitable. This makes newborn babies more susceptible 
to inflammation induced hyper-excitability and febrile seizures (Yirmiya and Goshen, 
2011). In addition, it decreases the ability to induce LTP, among other mechanisms, 
and therefore it can result in memory and learning disabilities. Hyper-excitability, 
although not yet fully understood, could be a mechanism to help on explaining the shift 
between the beneficial function to a harmful one of the immune system. When in 
continuum, as it happens under inflammatory conditions, hyper-exicitability may 
widespread in the brain, and therefore be a brain damage causing factor (Ding et al., 
2011). In addition, the dopaminergic system is usually associated with the reward 
system, but as well with movement control. Also, dopaminergic inputs into the 
hippocampus and frontal cortex are also relevant in learning, attention and decision 
making (Ernst and Paulus, 2005). Thus, when evaluating the levels of dopamine and its 
metabolites in the hippocampus of GBS-survivors, a significant decrease of both DA 
and DOPAC was observed, when comparing to age matched controls (Figure 14). This 
data set is also in agreement with the significant learning and memory disabilities found 
in children that survive to meningitis (Grimwood et al., 1995). Moreover, dopamine 
plays an important role in the nigrostriatal pathway, which connects the substantia 
nigra with the striatum (Graybiel et al., 1994, Schultz, 2002).It is particularly involved in 
the production of movement, as part of a system called the basal ganglia motor loop. 
Inputs from the cerebral cortex are received in the basal ganglia and substantia nigra 
(Schultz, 2002). The output of these two are the primary motor cortex and via the 
thalamus, the premotor cortex. The neurotransmitters GABA, glutamate and dopamine 
play central roles in the basal ganglia motor loop, as dopaminergic projects to the 
striatal region of the brain are also involved with motor control (Middleton and Strick, 
2000). As shown in Figure 12, the mice that survived to neonatal GBS infection, 
presented reduced global activity, in accordance with the decreased levels of the DA 
metabolites, DOPAC and HVA, in the striatum (Figure 15), which indicate reduced DA 
metabolism. Of note, this can lead to a decreased influx of glutamate from the 
thalamus to the motor cortex and thus result in hypokinesia, which is characterized by 
an abnormal decrease in muscular movement (Cauli et al., 2009a). In accordance, we 
detected significantly lower glutamate levels in the thalamus of the GBS-survivor 
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animals (Figure 13). Interestingly, reduced glutamate levels were previously associated 
with hypokenesia in a rodent model of encephalopathy (Cauli et al., 2009b) 
GBS-survivor mice presented a meaningful number of alterations in both 
learning and in spontaneous behavior. These data are in agreement with the observed 
decreased neurotransmitter levels in the brain sections of the same group of mice. 
Both glutamatergic and doparminergic function seem to be affect and thus influencing 
the normal function of the hippocampus and the strial-thalamic circuit as well. 
Taking into account all the above results we can conclude that our mouse 
model mimics the human neonatal diseases induced by GBS infection. 
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Concluding Remarks 
The precise mechanisms by which GBS cause meningitis are not yet fully 
understood. Until now, all the existing models use infection routes that do not mimic the 
human pathogenesis of ascending infection of neonates as they bypass the normal 
bacteremia-meningitis sequence.  
Our experimental model of GBS-induced meningitis is the first to mimic the 
natural course of human pathogenesis of neonatal infection through vertical 
transmission during gestation/birth. Indeed, we verified that pups born from GBS 
colonized mothers are infected during labor; these neonates present bacterial load in 
lungs, in blood, in liver and in brain. Moreover, the brains of infected pups showed the 
classical features of meningitis such as: meningeal thickening, cerebral bleeding and 
massive influx of inflammatory cells. In adulthood these mice present neurological 
sequelae, since they learn worse, are less active and curious than the non-infected 
controls. All these behavior alterations have been confirm by an altered 
neurotransmission pattern. Thus, all the obtained results were consistent with those 
observed in humans.  
Moreover, this model brings new insights about LOD transmission, to our 
knowledge this is the first experimental study to report mother-to-child transmission. 
This will help explain LOD cases and the morbidity and neurological sequeale 
associated.  
This novel experimental animal model could be used to explore and to 
characterize the pathophysiological mechanisms of the CNS inflammatory response 
and neuronal damage induced by GBS infection important for the development of new 
therapeutic approaches. 
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